Newborn and Developmental Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
Am J Perinatol. 2023 Aug;40(11):1223-1231. doi: 10.1055/s-0041-1735214. Epub 2021 Sep 28.
An alternative therapy for preterm infants with a hemodynamically significant patent ductus arteriosus (hsPDA) is needed when cyclooxygenase inhibitors fail or where treatment is contraindicated due to coexisting renal failure, necrotizing enterocolitis, and/or intestinal perforation. No studies have evaluated the efficacy of per rectum (PR) acetaminophen. The study aimed to evaluate the efficacy of PR acetaminophen in modulating the risk of PDA ligation.
A retrospective matched case-control study was conducted to compare neonates born <29 weeks' gestation with evidence of hsDA, in an era when rescue rectal acetaminophen was used (January 2014-March 2018) as a treatment strategy, versus historical controls (July 2006-August 2012). All patients underwent comprehensive echocardiography assessment of ductal shunt volume according to a standardized protocol. Acetaminophen treated neonates were matched according to demographics, gestation, preintervention echocardiography features, and comorbidities. Control patients were selected when an echocardiography was performed at an equivalent postnatal age. Infants with a genetic syndrome, severe congenital malformation, or major forms of congenital heart disease excluding small atrial septal defect or ventricular septal defect, PDA, or patent formale ovale were excluded. The primary outcome was surgical ligation of the PDA. Secondary outcomes included echocardiography indices of hemodynamic significance, the composite of death, or severe BPD (defined by ventilator dependence at 36 weeks postmenstrual age). Descriptive statistics and univariate (-tests, Fisher's exact test, and Mann-Whitney U test) analyses were used to evaluate clinical and echocardiography characteristics of the groups and compare outcomes.
Forty infants (20 cases and 20 controls), with similar demographic and echocardiography features, were compared. Cases received 6.8 ± 0.7 days (60 mg/kg/day) of PR acetaminophen. Responders ( = 12, 60%) had echocardiography evidence of reduced ductal diameter (2.2 mm [1.9-2.6] to 1.1 mm [0-1.7], = 0.002), left ventricular output (363 ± 108-249 ± 61 mL/min/kg; = 0.002) and left atrium to aortic root ratio (1.7 ± 0.3-1.3 ± 0.2; = 0.002) following treatment. The rate of PDA ligation was 50% lower ( = 0.02) and composite outcome of death or severe bronchopulmonary dysplasia was reduced ( = 0.04) in the acetaminophen group.
Rectal acetaminophen was associated with improvement in echocardiography indices of PDA shunt volume, a 50% reduction in PDA ligation rates and a reduction in the composite outcome of death or severe BPD. Pharmacologic and further prospective clinical studies are needed.
· Many preterm infants encounter the clinical consequences of a hemodynamically significant PDA.. · The merits and optimal timing of PDA ligation remains an area of controversy amongst neonatologists.. · Cyclooxygenase inhibitors are associated with adverse events or are often contraindicated..
当环氧化酶抑制剂无效或由于并存的肾衰竭、坏死性小肠结肠炎和/或肠穿孔而存在治疗禁忌时,需要为患有血流动力学显著动脉导管未闭(hsPDA)的早产儿寻找替代疗法。尚无研究评估直肠内(PR)对乙酰氨基酚的疗效。本研究旨在评估 PR 对乙酰氨基酚在调节 PDA 结扎风险方面的疗效。
进行了一项回顾性匹配病例对照研究,比较了在使用抢救性直肠内对乙酰氨基酚作为治疗策略的时代(2014 年 1 月至 2018 年 3 月)出生的 <29 周胎龄且存在 hsDA 证据的新生儿与历史对照(2006 年 7 月至 2012 年 8 月)。所有患者均根据标准化方案接受全面的超声心动图评估导管分流量。根据人口统计学、胎龄、干预前超声心动图特征和合并症,对接受对乙酰氨基酚治疗的新生儿进行匹配。当在相当的产后年龄进行超声心动图检查时,选择对照患者。排除具有遗传综合征、严重先天性畸形或除小房间隔缺损或室间隔缺损、PDA 或开放性卵圆孔外的主要形式先天性心脏病的婴儿。主要结局是 PDA 的手术结扎。次要结局包括超声心动图显示的血流动力学显著指数、死亡或严重 BPD(定义为在 36 周校正胎龄时需要呼吸机支持)的复合结局。使用描述性统计和单变量(检验、Fisher 确切检验和 Mann-Whitney U 检验)分析来评估组间的临床和超声心动图特征,并比较结局。
比较了 40 名婴儿(20 例病例和 20 例对照),他们具有相似的人口统计学和超声心动图特征。病例接受了 6.8 ± 0.7 天(60mg/kg/天)的 PR 对乙酰氨基酚。有反应者(n=12,60%)的超声心动图显示导管直径缩小(2.2mm[1.9-2.6]至 1.1mm[0-1.7], = 0.002),左心室输出量(363 ± 108-249 ± 61mL/min/kg; = 0.002)和左心房与主动脉根比值(1.7 ± 0.3-1.3 ± 0.2; = 0.002)。在治疗后,PDA 结扎率降低了 50%( = 0.02),死亡或严重支气管肺发育不良的复合结局减少( = 0.04)。
直肠内对乙酰氨基酚与 PDA 分流体积的超声心动图指数改善相关,PDA 结扎率降低了 50%,死亡或严重 BPD 的复合结局减少。需要进行药理学和进一步的前瞻性临床研究。
·许多早产儿会遇到血流动力学显著 PDA 的临床后果。·PDA 结扎的优点和最佳时机仍然是新生儿科医生之间存在争议的领域。·环氧化酶抑制剂存在不良反应或经常存在治疗禁忌。